Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Weight-loss surgery shows stronger 10-year health benefits than popular meds, study finds
Over nearly six to ten years, individuals with obesity and type 2 diabetes who had metabolic (bariatric) surgery showed significantly lower risks of death, ... Read More
Weight loss drugs could add years to Americans' lives, researchers project
New research reveals that GLP-1 drugs may significantly lower mortality rates in Americans by 2045, as obesity contributes to 70% of leading death causes in high-income countries. Read More
New weight-loss pill could expand access to popular drugs
A once-a-day tablet for obesity could expand the use of weight-loss drugs to many people who have struggled to access them before, experts have said, after a new study found the pill can lead to ... Read More
Pill Version of Ozempic and Wegovy Leads to 13% Weight Loss in Study
Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial. Read More
Wegovy linked to lower heart risks than similar drugs, study suggests
The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 ... Read More
GLP-1 drugs such as Lilly’s Mounjaro and Novo’s Ozempic linked to lower cancer risk: study
GLP-1 receptor agonists such as the popular weight loss/diabetes therapies Mounjaro, developed by Eli Lilly (NYSE:LLY), and Ozempic, developed by Novo Nordisk (NVO), can reduce cancer risk, according ... Read More
Genetic test predicts response to weight-loss drugs
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Read More
Weight loss drugs may be helping Gen Z’s get sober, study finds
73% of patients said weight-loss drugs like Ozempic and Wegovy helped them cut down on substance use. Many reported fewer cravings, slips, and even quitting altogether. Experts believe these ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus